Insiders · Profile

Kelley Kenneth J

Director at HALOZYME THERAPEUTICS. Filing since 14 Mar 2007. CIK 0001291219

Company
Date
Role
Action
Shares
Amount
Of holding
14 Apr 2021
Director
Sold, plan not stated
5,000
$225.00K
2.7%
1 Mar 2021
Director
Sold, plan not stated
5,000
$226.72K
2.6%
1 Feb 2021
Director
Sold, plan not stated
5,000
$240.59K
2.6%
4 Jan 2021
Director
Sold, plan not stated
5,000
$214.56K
2.5%
7 Dec 2020
Director
Sold, plan not stated
35,086
$1.44M
14.9%
2 Dec 2020
Director
Sold, plan not stated
31,792
$1.30M
11.9%
27 Nov 2020
Director
Sold, plan not stated
10,000
$412.50K
3.6%
25 Nov 2020
Director
Sold, plan not stated
9,671
$401.35K
3.4%
19 Mar 2020
Director
Bought
52,629
$748.70K
23.4%
18 Jun 2015
Director
Sold, plan not stated
20,000
$420.00K
9.2%
5 Mar 2015
Director
Sold, plan not stated
40,000
$613.38K
17.0%
27 Aug 2012
Director
Bought
20,000
$113.97K
15.4%
14 May 2012
Director
Bought
20,000
$149.80K
18.2%
25 May 2007
Director
Sold, plan not stated
22,500
$230.94K
60.0%
18 May 2007
Director
Sold, plan not stated
15,000
$158.29K
50.0%
7 May 2007
Director
Sold, plan not stated
12,500
$130.03K
45.5%
30 Apr 2007
Director
Sold, plan not stated
25,000
$257.96K
62.5%
23 Apr 2007
Director
Sold, plan not stated
25,000
$221.02K
62.5%
16 Apr 2007
Director
Sold, plan not stated
25,000
$226.72K
62.5%
9 Apr 2007
Director
Sold, plan not stated
25,000
$211.48K
62.5%
2 Apr 2007
Director
Sold, plan not stated
25,000
$201.26K
62.5%
27 Mar 2007
Director
Sold, plan not stated
8,738
$72.69K
36.8%
26 Mar 2007
Director
Sold, plan not stated
16,262
$136.66K
40.7%
19 Mar 2007
Director
Sold, plan not stated
25,000
$217.59K
62.5%
14 Mar 2007
Director
Sold, plan not stated
25,000
$198.95K
62.5%
25 decisions on file.